undamentalytics Newsletter
Sign in

Renovorx, Inc. revenue

Renovorx, Inc.'s revenue was $1.1m in fiscal 2025, up 2511.6% on the year before. Over the last twelve months it was $2.0m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Revenue431,1231,976
Growth on the year before—+>999%—
Gross profit437961,668

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Renovorx, Inc. $2.0m — —
Seastar Medical Holding Corp $1.7m 123.6% —
Femasys Inc $2.3m 21.9% 24.3%
Insight Molecular Diagnostics Inc. $1.7m -60.8% 14.9%
Volitionrx LTD $2.5m 86.3% 68.0%
Pulse Biosciences, Inc. $1.2m 100.0% —

Compare with peers

Head to head: ICU vs RNXTFEMY vs RNXTIMDX vs RNXT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Renovorx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Renovorx, Inc.